LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 10

Search options

  1. Article ; Online: SIV Infection Is Associated with Transient Acute-Phase Steatosis in Hepatocytes In Vivo.

    Derby, Nina / Biswas, Sreya / Yusova, Sofiya / Luevano-Santos, Cristina / Pacheco, Maria Cristina / Meyer, Kimberly A / Johnson, Brooke I / Fischer, Miranda / Fancher, Katherine A / Fisher, Cole / Abraham, Yohannes M / McMahon, Conor J / Lutz, Savannah S / Smedley, Jeremy V / Burwitz, Benjamin J / Sodora, Donald L

    Viruses

    2024  Volume 16, Issue 2

    Abstract: Metabolic-dysfunction-associated fatty liver disease (MAFLD) is a major cause of morbidity and mortality in HIV-infected individuals, even those receiving optimal antiretroviral therapy. Here, we utilized the SIV rhesus macaque model and advanced ... ...

    Abstract Metabolic-dysfunction-associated fatty liver disease (MAFLD) is a major cause of morbidity and mortality in HIV-infected individuals, even those receiving optimal antiretroviral therapy. Here, we utilized the SIV rhesus macaque model and advanced laparoscopic techniques for longitudinal collection of liver tissue to elucidate the timing of pathologic changes. The livers of both SIV-infected (N = 9) and SIV-naïve uninfected (N = 8) macaques were biopsied and evaluated at four time points (weeks -4, 2, 6, and 16-20 post-infection) and at necropsy (week 32). SIV DNA within the macaques' livers varied by over 4 logs at necropsy, and liver SIV DNA significantly correlated with SIV RNA in the plasma throughout the study. Acute phase liver pathology (2 weeks post-infection) was characterized by evidence for fat accumulation (microvesicular steatosis), a transient elevation in both AST and cholesterol levels within the serum, and increased hepatic expression of the PPARA gene associated with cholesterol metabolism and beta oxidation. By contrast, the chronic phase of the SIV infection (32 weeks post-infection) was associated with sinusoidal dilatation, while steatosis resolved and concentrations of AST and cholesterol remained similar to those in uninfected macaques. These findings suggest differential liver pathologies associated with the acute and chronic phases of infection and the possibility that therapeutic interventions targeting metabolic function may benefit liver health in people newly diagnosed with HIV.
    MeSH term(s) Animals ; Humans ; Simian Acquired Immunodeficiency Syndrome/drug therapy ; Simian Immunodeficiency Virus ; Macaca mulatta ; HIV Infections/complications ; Fatty Liver ; Hepatocytes/metabolism ; DNA ; Cholesterol
    Chemical Substances DNA (9007-49-2) ; Cholesterol (97C5T2UQ7J)
    Language English
    Publishing date 2024-02-15
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2516098-9
    ISSN 1999-4915 ; 1999-4915
    ISSN (online) 1999-4915
    ISSN 1999-4915
    DOI 10.3390/v16020296
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: A Multifunctional and Highly Adaptable Reporter System for CRISPR/Cas Editing.

    Wettengel, Jochen M / Hansen-Palmus, Lea / Yusova, Sofiya / Rust, Lauren / Biswas, Sreya / Carson, Julien / Ryu, Junghyun / Bimber, Benjamin N / Hennebold, Jon D / Burwitz, Benjamin J

    International journal of molecular sciences

    2023  Volume 24, Issue 9

    Abstract: CRISPR/Cas systems are some of the most promising tools for therapeutic genome editing. The use of these systems is contingent on the optimal designs of guides and homology-directed repair (HDR) templates. While this design can be achieved in silico, ... ...

    Abstract CRISPR/Cas systems are some of the most promising tools for therapeutic genome editing. The use of these systems is contingent on the optimal designs of guides and homology-directed repair (HDR) templates. While this design can be achieved in silico, validation and further optimization are usually performed with the help of reporter systems. Here, we describe a novel reporter system, termed BETLE, that allows for the fast, sensitive, and cell-specific detection of genome editing and template-specific HDR by encoding multiple reporter proteins in different open-reading frames. Out-of-frame non-homologous end joining (NHEJ) leads to the expression of either secretable NanoLuc luciferase, enabling a highly sensitive and low-cost analysis of editing, or fluorescent mTagBFP2, allowing for the enumeration and tissue-specific localization of genome-edited cells. BETLE includes a site to validate CRISPR/Cas systems for a sequence-of-interest, making it broadly adaptable. We evaluated BETLE using a defective moxGFP with a 39-base-pair deletion and showed spCas9, saCas9, and asCas12a editing as well as sequence-specific HDR and the repair of moxGFP in cell lines with single and multiple reporter integrants. Taken together, these data show that BETLE allows for the rapid detection and optimization of CRISPR/Cas genome editing and HDR in vitro and represents a state-of the art tool for future applications in vivo.
    MeSH term(s) CRISPR-Cas Systems/genetics ; DNA Breaks, Double-Stranded ; Gene Editing ; DNA End-Joining Repair ; Genome
    Language English
    Publishing date 2023-05-05
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2019364-6
    ISSN 1422-0067 ; 1422-0067 ; 1661-6596
    ISSN (online) 1422-0067
    ISSN 1422-0067 ; 1661-6596
    DOI 10.3390/ijms24098271
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Improved production of cytotoxic thailanstatins A and D through metabolic engineering of

    Liu, Xiangyang / Zhu, Hui / Biswas, Sreya / Cheng, Yi-Qiang

    Synthetic and systems biotechnology

    2016  Volume 1, Issue 1, Page(s) 34–38

    Abstract: Thailanstatin A (TST-A) is a potent antiproliferative natural product discovered by our group ... ...

    Abstract Thailanstatin A (TST-A) is a potent antiproliferative natural product discovered by our group from
    Language English
    Publishing date 2016-04-01
    Publishing country China
    Document type Journal Article
    ISSN 2405-805X
    ISSN 2405-805X
    DOI 10.1016/j.synbio.2016.02.002
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Development of a Novel, Small-Molecule Brain-Penetrant Histone Deacetylase Inhibitor That Enhances Spatial Memory Formation in Mice.

    Belayet, Jawad B / Beamish, Sarah / Rahaman, Mizzanoor / Alanani, Samer / Virdi, Rajdeep S / Frick, David N / Rahman, A F M Towheedur / Ulicki, Joseph S / Biswas, Sreya / Arnold, Leggy A / Roni, M S Rashid / Cheng, Eric Y / Steeber, Douglas A / Frick, Karyn M / Hossain, M Mahmun

    Journal of medicinal chemistry

    2022  Volume 65, Issue 4, Page(s) 3388–3403

    Abstract: Histone acetylation is a prominent epigenetic modification linked to the memory loss symptoms associated with neurodegenerative disease. The use of existing histone deacetylase inhibitor (HDACi) drugs for treatment is precluded by their weak blood-brain ... ...

    Abstract Histone acetylation is a prominent epigenetic modification linked to the memory loss symptoms associated with neurodegenerative disease. The use of existing histone deacetylase inhibitor (HDACi) drugs for treatment is precluded by their weak blood-brain barrier (BBB) permeability and undesirable toxicity. Here, we address these shortcomings by developing a new class of disulfide-based compounds, inspired by the scaffold of the FDA-approved HDACi romidepsin (FK288). Our findings indicate that our novel compound MJM-1 increases the overall level of histone 3 (H3) acetylation in a prostate cancer cell line. In mice, MJM-1 injected intraperitoneally (i.p.) crossed the BBB and could be detected in the hippocampus, a brain region that mediates memory. Consistent with this finding, we found that the post-training i.p. administration of MJM-1 enhanced hippocampus-dependent spatial memory consolidation in male mice. Therefore, MJM-1 represents a potential lead for further optimization as a therapeutic strategy for ameliorating cognitive deficits in aging and neurodegenerative diseases.
    MeSH term(s) Animals ; Brain/metabolism ; Cell Line, Tumor ; Histone Deacetylase Inhibitors/chemical synthesis ; Histone Deacetylase Inhibitors/pharmacokinetics ; Histone Deacetylase Inhibitors/pharmacology ; Mice ; Mice, Inbred BALB C ; Spatial Memory/drug effects
    Chemical Substances Histone Deacetylase Inhibitors
    Language English
    Publishing date 2022-02-08
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Research Support, U.S. Gov't, Non-P.H.S.
    ZDB-ID 218133-2
    ISSN 1520-4804 ; 0022-2623
    ISSN (online) 1520-4804
    ISSN 0022-2623
    DOI 10.1021/acs.jmedchem.1c01928
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Isolation and characterization of spliceostatin B, a new analogue of FR901464, from Pseudomonas sp. No. 2663.

    Liu, Xiangyang / Biswas, Sreya / Tang, Gong-Li / Cheng, Yi-Qiang

    The Journal of antibiotics

    2013  Volume 66, Issue 9, Page(s) 555–558

    MeSH term(s) Enzyme Inhibitors/chemistry ; Enzyme Inhibitors/isolation & purification ; Enzyme Inhibitors/pharmacology ; Magnetic Resonance Spectroscopy ; Models, Molecular ; Molecular Structure ; Pseudomonas/chemistry ; Pyrans/chemistry ; Spiro Compounds/chemistry ; Spiro Compounds/isolation & purification ; Spiro Compounds/pharmacology ; Spliceosomes/metabolism
    Chemical Substances Enzyme Inhibitors ; FR 901464 ; Pyrans ; Spiro Compounds
    Language English
    Publishing date 2013-05-08
    Publishing country Japan
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 390800-8
    ISSN 1881-1469 ; 0021-8820 ; 0368-3532
    ISSN (online) 1881-1469
    ISSN 0021-8820 ; 0368-3532
    DOI 10.1038/ja.2013.38
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Long-term hepatitis B virus infection of rhesus macaques requires suppression of host immunity.

    Biswas, Sreya / Rust, Lauren N / Wettengel, Jochen M / Yusova, Sofiya / Fischer, Miranda / Carson, Julien N / Johnson, Josie / Wei, Lei / Thode, Trason / Kaadige, Mohan R / Sharma, Sunil / Agbaria, Majd / Bimber, Benjamin N / Tu, Thomas / Protzer, Ulrike / Ploss, Alexander / Smedley, Jeremy V / Golomb, Gershon / Sacha, Jonah B /
    Burwitz, Benjamin J

    Nature communications

    2022  Volume 13, Issue 1, Page(s) 2995

    Abstract: Hepatitis B virus has infected a third of the world's population, and 296 million people are living with chronic infection. Chronic infection leads to progressive liver disease, including hepatocellular carcinoma and liver failure, and there remains no ... ...

    Abstract Hepatitis B virus has infected a third of the world's population, and 296 million people are living with chronic infection. Chronic infection leads to progressive liver disease, including hepatocellular carcinoma and liver failure, and there remains no reliable curative therapy. These gaps in our understanding are due, in large part, to a paucity of animal models of HBV infection. Here, we show that rhesus macaques regularly clear acute HBV infection, similar to adult humans, but can develop long-term infection if immunosuppressed. Similar to patients, we longitudinally detected HBV DNA, HBV surface antigen, and HBV e antigen in the serum of experimentally infected animals. In addition, we discovered hallmarks of HBV infection in the liver, including RNA transcription, HBV core and HBV surface antigen translation, and covalently closed circular DNA biogenesis. This pre-clinical animal model will serve to accelerate emerging HBV curative therapies into the clinic.
    MeSH term(s) Animals ; Antigens, Surface ; Hepatitis B ; Hepatitis B virus/genetics ; Hepatitis B, Chronic ; Humans ; Liver Neoplasms ; Macaca mulatta
    Chemical Substances Antigens, Surface
    Language English
    Publishing date 2022-05-30
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 2553671-0
    ISSN 2041-1723 ; 2041-1723
    ISSN (online) 2041-1723
    ISSN 2041-1723
    DOI 10.1038/s41467-022-30593-0
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Therapeutic neutralizing monoclonal antibody administration protects against lethal yellow fever virus infection.

    Ricciardi, Michael J / Rust, Lauren N / Pedreño-Lopez, Nuria / Yusova, Sofiya / Biswas, Sreya / Webb, Gabriela M / Gonzalez-Nieto, Lucas / Voigt, Thomas B / Louw, Johan J / Laurino, Fernanda D / DiBello, John R / Raué, Hans-Peter / Barber-Axthelm, Aaron M / Chun, Kimberly / Uttke, Samantha / Raphael, Lidiane M S / Yrizarry-Medina, Aaron / Rosen, Brandon C / Agnor, Rebecca /
    Gao, Lina / Labriola, Caralyn / Axthelm, Michael / Smedley, Jeremy / Julander, Justin G / Bonaldo, Myrna C / Walker, Laura M / Messaoudi, Ilhem / Slifka, Mark K / Burton, Dennis R / Kallas, Esper G / Sacha, Jonah B / Watkins, David I / Burwitz, Benjamin J

    Science translational medicine

    2023  Volume 15, Issue 689, Page(s) eade5795

    Abstract: Yellow fever virus (YFV) is a reemerging global health threat, driven by several factors, including increased spread of the mosquito vector and rapid urbanization. Although a prophylactic vaccine exists, vaccine hesitancy, supply deficits, and ... ...

    Abstract Yellow fever virus (YFV) is a reemerging global health threat, driven by several factors, including increased spread of the mosquito vector and rapid urbanization. Although a prophylactic vaccine exists, vaccine hesitancy, supply deficits, and distribution difficulties leave specific populations at risk of severe YFV disease, as evidenced by recent outbreaks in South America. To establish a treatment for patients with severe YFV infection, we tested 37 YFV-specific monoclonal antibodies isolated from vaccinated humans and identified two capable of potently neutralizing multiple pathogenic primary YFV isolates. Using both hamster and nonhuman primate models of lethal YFV infection, we demonstrate that a single administration of either of these two potently neutralizing antibodies during acute infection fully controlled viremia and prevented severe disease and death in treated animals. Given the potential severity of YFV-induced disease, our results show that these antibodies could be effective in saving lives and fill a much-needed void in managing YFV cases during outbreaks.
    MeSH term(s) Cricetinae ; Animals ; Humans ; Yellow fever virus ; Antibodies, Neutralizing/therapeutic use ; Yellow Fever Vaccine/adverse effects ; Yellow Fever/prevention & control ; Antibodies, Viral/therapeutic use ; Antibodies, Monoclonal/therapeutic use
    Chemical Substances Antibodies, Neutralizing ; Yellow Fever Vaccine ; Antibodies, Viral ; Antibodies, Monoclonal
    Language English
    Publishing date 2023-03-29
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 2518854-9
    ISSN 1946-6242 ; 1946-6234
    ISSN (online) 1946-6242
    ISSN 1946-6234
    DOI 10.1126/scitranslmed.ade5795
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: MHC-E-Restricted CD8

    Burwitz, Benjamin J / Hashiguchi, Patrick K / Mansouri, Mandana / Meyer, Christine / Gilbride, Roxanne M / Biswas, Sreya / Womack, Jennie L / Reed, Jason S / Wu, Helen L / Axthelm, Michael K / Hansen, Scott G / Picker, Louis J / Früh, Klaus / Sacha, Jonah B

    Journal of immunology (Baltimore, Md. : 1950)

    2020  Volume 204, Issue 8, Page(s) 2169–2176

    Abstract: Currently 247 million people are living with chronic hepatitis B virus infection (CHB), and the development of novel curative treatments is urgently needed. Immunotherapy is an attractive approach to treat CHB, yet therapeutic approaches to augment the ... ...

    Abstract Currently 247 million people are living with chronic hepatitis B virus infection (CHB), and the development of novel curative treatments is urgently needed. Immunotherapy is an attractive approach to treat CHB, yet therapeutic approaches to augment the endogenous hepatitis B virus (HBV)-specific T cell response in CHB patients have demonstrated little success. In this study, we show that strain 68-1 rhesus macaque (RM) CMV vaccine vectors expressing HBV Ags engender HBV-specific CD8
    MeSH term(s) Animals ; CD8-Positive T-Lymphocytes/immunology ; Hepatitis B virus/immunology ; Hepatitis B, Chronic/immunology ; Hepatitis B, Chronic/virology ; Hepatocytes/immunology ; Hepatocytes/virology ; Histocompatibility Antigens Class I/immunology ; Macaca mulatta
    Chemical Substances Histocompatibility Antigens Class I
    Language English
    Publishing date 2020-03-11
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 3056-9
    ISSN 1550-6606 ; 0022-1767 ; 1048-3233 ; 1047-7381
    ISSN (online) 1550-6606
    ISSN 0022-1767 ; 1048-3233 ; 1047-7381
    DOI 10.4049/jimmunol.1900795
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Genomics-guided discovery of thailanstatins A, B, and C As pre-mRNA splicing inhibitors and antiproliferative agents from Burkholderia thailandensis MSMB43.

    Liu, Xiangyang / Biswas, Sreya / Berg, Michael G / Antapli, Christopher M / Xie, Feng / Wang, Qi / Tang, Man-Cheng / Tang, Gong-Li / Zhang, Lixin / Dreyfuss, Gideon / Cheng, Yi-Qiang

    Journal of natural products

    2013  Volume 76, Issue 4, Page(s) 685–693

    Abstract: Mining the genome sequence of Burkholderia thailandensis MSMB43 revealed a cryptic biosynthetic gene cluster resembling that of FR901464 (4), a prototype spliceosome inhibitor produced by Pseudomonas sp. No. 2663. Transcriptional analysis revealed a ... ...

    Abstract Mining the genome sequence of Burkholderia thailandensis MSMB43 revealed a cryptic biosynthetic gene cluster resembling that of FR901464 (4), a prototype spliceosome inhibitor produced by Pseudomonas sp. No. 2663. Transcriptional analysis revealed a cultivation condition in which a regulatory gene of the cryptic gene cluster is adequately expressed. Consequently, three new compounds, named thailanstatins A (1), B (2), and C (3), were isolated from the fermentation broth of B. thailandensis MSMB43. Thailanstatins are proposed to be biosynthesized by a hybrid polyketide synthase-nonribosomal peptide synthetase pathway. They differ from 4 by lacking an unstable hydroxyl group and by having an extra carboxyl moiety; those differences endow thailanstatins with a significantly greater stability than 4 as tested in phosphate buffer at pH 7.4. In vitro assays showed that thailanstatins inhibit pre-mRNA splicing as potently as 4, with half-maximal inhibitory concentrations in the single to sub-μM range. Cell culture assays indicated that thailanstatins also possess potent antiproliferative activities in representative human cancer cell lines, with half-maximal growth inhibitory concentrations in the single nM range. This work provides new chemical entities for research and development and new structure-activity information for chemical optimization of related spliceosome inhibitors.
    MeSH term(s) Antineoplastic Agents/chemistry ; Antineoplastic Agents/isolation & purification ; Antineoplastic Agents/pharmacology ; Burkholderia/chemistry ; Drug Screening Assays, Antitumor ; Genomics ; Humans ; Multigene Family ; Pseudomonas/chemistry ; Pyrans/chemistry ; Pyrans/isolation & purification ; Pyrans/pharmacology ; RNA Precursors/drug effects ; Spiro Compounds/chemistry ; Spiro Compounds/isolation & purification ; Structure-Activity Relationship
    Chemical Substances Antineoplastic Agents ; FR 901464 ; Pyrans ; RNA Precursors ; Spiro Compounds ; thailanstatin A ; thailanstatin B ; thailanstatin C
    Language English
    Publishing date 2013-03-21
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 304325-3
    ISSN 1520-6025 ; 0163-3864
    ISSN (online) 1520-6025
    ISSN 0163-3864
    DOI 10.1021/np300913h
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: Genomics-Guided Discovery of Thailanstatins A, B, and C As Pre-mRNA Splicing Inhibitors and Antiproliferative Agents from Burkholderia thailandensis MSMB43

    Liu, Xiangyang / Biswas Sreya / Berg Michael G / Antapli Christopher M / Xie Feng / Wang Qi / Tang Man-Cheng / Tang Gong-Li / Zhang Lixin / Dreyfuss Gideon / Cheng Yi-Qiang

    Journal of natural products. 2013 Apr. 26, v. 76, no. 4

    2013  

    Abstract: Mining the genome sequence of Burkholderia thailandensis MSMB43 revealed a cryptic biosynthetic gene cluster resembling that of FR901464 (4), a prototype spliceosome inhibitor produced by Pseudomonas sp. No. 2663. Transcriptional analysis revealed a ... ...

    Abstract Mining the genome sequence of Burkholderia thailandensis MSMB43 revealed a cryptic biosynthetic gene cluster resembling that of FR901464 (4), a prototype spliceosome inhibitor produced by Pseudomonas sp. No. 2663. Transcriptional analysis revealed a cultivation condition in which a regulatory gene of the cryptic gene cluster is adequately expressed. Consequently, three new compounds, named thailanstatins A (1), B (2), and C (3), were isolated from the fermentation broth of B. thailandensis MSMB43. Thailanstatins are proposed to be biosynthesized by a hybrid polyketide synthase–nonribosomal peptide synthetase pathway. They differ from 4 by lacking an unstable hydroxyl group and by having an extra carboxyl moiety; those differences endow thailanstatins with a significantly greater stability than 4 as tested in phosphate buffer at pH 7.4. In vitro assays showed that thailanstatins inhibit pre-mRNA splicing as potently as 4, with half-maximal inhibitory concentrations in the single to sub-μM range. Cell culture assays indicated that thailanstatins also possess potent antiproliferative activities in representative human cancer cell lines, with half-maximal growth inhibitory concentrations in the single nM range. This work provides new chemical entities for research and development and new structure–activity information for chemical optimization of related spliceosome inhibitors.
    Keywords Burkholderia thailandensis ; Pseudomonas ; anticarcinogenic activity ; buffers ; cell culture ; culture media ; humans ; in vitro studies ; multigene family ; neoplasms ; nucleotide sequences ; pH ; phosphates ; polyketide synthases ; regulator genes ; spliceosomes ; transcription (genetics)
    Language English
    Dates of publication 2013-0426
    Size p. 685-693.
    Publishing place American Chemical Society and American Society of Pharmacognosy
    Document type Article
    ZDB-ID 304325-3
    ISSN 1520-6025 ; 0163-3864
    ISSN (online) 1520-6025
    ISSN 0163-3864
    DOI 10.1021%2Fnp300913h
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

To top